Scott Dodds

Array ( [id] => 4949859 [patent_doc_number] => 20080305985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Isosteric Transormation' [patent_app_type] => utility [patent_app_number] => 10/593276 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5387 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305985.pdf [firstpage_image] =>[orig_patent_app_number] => 10593276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801260 [patent_doc_number] => 20060035814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Reagents and methods for smooth muscle therapies' [patent_app_type] => utility [patent_app_number] => 11/078256 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15517 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035814.pdf [firstpage_image] =>[orig_patent_app_number] => 11078256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7257653 [patent_doc_number] => 20050143565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Method for separating unmodified hemoglobin from cross-linked hemoglobin' [patent_app_type] => utility [patent_app_number] => 11/071672 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5198 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143565.pdf [firstpage_image] =>[orig_patent_app_number] => 11071672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005007 [patent_doc_number] => 20070202577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Method For The Production Of Hyperbranched Polysaccharide Fractions' [patent_app_type] => utility [patent_app_number] => 10/590676 [patent_app_country] => US [patent_app_date] => 2005-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3184 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202577.pdf [firstpage_image] =>[orig_patent_app_number] => 10590676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291172 [patent_doc_number] => 20090023902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Method for the extraction of intracellular proteins from a fermentation broth' [patent_app_type] => utility [patent_app_number] => 10/590185 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8070 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023902.pdf [firstpage_image] =>[orig_patent_app_number] => 10590185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6996268 [patent_doc_number] => 20050136046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Methods of using therapeutic fibrinogen compositions' [patent_app_type] => utility [patent_app_number] => 11/058489 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9841 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136046.pdf [firstpage_image] =>[orig_patent_app_number] => 11058489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311081 [patent_doc_number] => 07528105 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-05 [patent_title] => 'Heterodimeric chain synthetic heparin-binding growth factor analogs' [patent_app_type] => utility [patent_app_number] => 11/055428 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16326 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528105.pdf [firstpage_image] =>[orig_patent_app_number] => 11055428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814803 [patent_doc_number] => 20060084606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Methods for reducing oxidative damage' [patent_app_type] => utility [patent_app_number] => 11/040242 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 14556 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084606.pdf [firstpage_image] =>[orig_patent_app_number] => 11040242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931714 [patent_doc_number] => 20050282749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes' [patent_app_type] => utility [patent_app_number] => 11/035826 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 35688 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282749.pdf [firstpage_image] =>[orig_patent_app_number] => 11035826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656443 [patent_doc_number] => 20060142179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => '4-aminopyridine and a pharmaceutical composition for treatment of neuronal disorders' [patent_app_type] => utility [patent_app_number] => 11/023241 [patent_app_country] => US [patent_app_date] => 2004-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4500 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142179.pdf [firstpage_image] =>[orig_patent_app_number] => 11023241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7199706 [patent_doc_number] => 20050164912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Methods for recovering cleaved peptide from a support after solid phase synthesis' [patent_app_type] => utility [patent_app_number] => 11/022197 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17365 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164912.pdf [firstpage_image] =>[orig_patent_app_number] => 11022197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905210 [patent_doc_number] => 20050100605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid' [patent_app_type] => utility [patent_app_number] => 11/013354 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6994 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100605.pdf [firstpage_image] =>[orig_patent_app_number] => 11013354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145299 [patent_doc_number] => 20050119185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Synthetic HLA binding peptide analogues and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/999425 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10863 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119185.pdf [firstpage_image] =>[orig_patent_app_number] => 10999425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069506 [patent_doc_number] => 20050244891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Ligand-containing micelles and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/997066 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 47896 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244891.pdf [firstpage_image] =>[orig_patent_app_number] => 10997066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6984055 [patent_doc_number] => 20050154125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Use of hydrophobic crosslinking agents to prepare crosslinked biomaterial compositions' [patent_app_type] => utility [patent_app_number] => 10/997246 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7950 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20050154125.pdf [firstpage_image] =>[orig_patent_app_number] => 10997246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103955 [patent_doc_number] => 20050106681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Enhanced solubility of recombinant proteins' [patent_app_type] => utility [patent_app_number] => 10/997535 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12424 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106681.pdf [firstpage_image] =>[orig_patent_app_number] => 10997535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159355 [patent_doc_number] => 07674771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Antimicrobial peptides and utilization of the same' [patent_app_type] => utility [patent_app_number] => 10/577688 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10097 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674771.pdf [firstpage_image] =>[orig_patent_app_number] => 10577688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 224937 [patent_doc_number] => 07605120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Antagonists of the brandykinin B1 receptor' [patent_app_type] => utility [patent_app_number] => 10/972236 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25816 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605120.pdf [firstpage_image] =>[orig_patent_app_number] => 10972236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111919 [patent_doc_number] => 07718618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Human cathelicidin antimicrobial peptides' [patent_app_type] => utility [patent_app_number] => 10/575552 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15528 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718618.pdf [firstpage_image] =>[orig_patent_app_number] => 10575552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43968 [patent_doc_number] => 07776823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Human cathelicidin antimicrobial peptides' [patent_app_type] => utility [patent_app_number] => 10/575537 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16397 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776823.pdf [firstpage_image] =>[orig_patent_app_number] => 10575537 [rel_patent_id] =>[rel_patent_doc_number] =>)